LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Reset all filters
01 1LGM Pharma
02 1HRV Pharma
03 1Mankind Pharma
04 1Almon Healthcare
05 1Arevipharma
06 2Aurore Life Sciences
07 1Ax Pharmaceutical Corporation
08 1Cambrex Corporation
09 1Global Calcium
10 1Jiangsu Nhwa Pharmaceutical
11 1Jin Dun Medical
12 1Matrix Pharmaceutical Inc
13 3Medichem S.A
14 1Medilux Laboratories
15 1Otto Brandes
16 1R L Fine Chem
17 1SHANGHAI ZHONGXI SUNVE PHARMACEUTICAL
18 1SMS Pharmaceuticals
19 1Sandoz B2B
20 1Shouguang Fukang Pharmaceutical Co., Ltd
21 1Smilax Laboratories Limited
22 1Viatris
23 1WUHAN SHIJI PHARMACEUTICAL CO LTD
24 1Wuhan Shiji Pharmaceutical
25 2Blank
Reset all filters
01 1Canada
02 6China
03 2Germany
04 10India
05 3Spain
06 1Switzerland
07 4U.S.A
08 2Blank
Reset all filters
01 11Active
02 4Inactive
03 14Blank
01 8Valid
02 1Withdrawn by Holder
03 20Blank
Reset all filters
01 1301MF10021
02 28Blank
Reset all filters
01 1WC-0015
02 1WC-0104
03 1WC-0373
04 1WC-0445
05 1WC-0542
06 24Blank
Reset all filters
01 120180903-209-J-157
02 120180903-209-J-157(1)
03 120180903-209-J-157(2)
04 26Blank
Reset all filters
01 112828-0072
02 153296-0033
03 164374-004
04 167835-0028
05 171554-025
06 173377-150
07 184206-0023
08 22Blank
01 29Blank
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Delivering quality and niche Active Pharmaceutical Ingredients across the global from our USFDA-approved facility.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37540
Submission : 2023-02-01
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39913
Submission : 2024-05-28
Status : Active
Type : II
Date of Issue : 2025-07-07
Valid Till : 2028-07-21
Written Confirmation Number : WC-0373
Address of the Firm :
NDC Package Code : 67835-0028
Start Marketing Date : 2021-09-17
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

GDUFA
DMF Review : Reviewed
Rev. Date : 2023-01-26
Pay. Date : 2022-12-12
DMF Number : 36645
Submission : 2021-12-23
Status : Active
Type : II
Certificate Number : CEP 2023-444 - Rev 00
Issue Date : 2024-03-28
Type : Chemical
Substance Number : 1191
Status : Valid
Date of Issue : 2022-09-12
Valid Till : 2025-08-12
Written Confirmation Number : WC-0542
Address of the Firm :

GDUFA
DMF Review : Reviewed
Rev. Date : 2014-08-29
Pay. Date : 2013-09-25
DMF Number : 25182
Submission : 2011-08-03
Status : Active
Type : II
Certificate Number : R1-CEP 2012-006 - Rev 00
Issue Date : 2018-04-12
Type : Chemical
Substance Number : 1191
Status : Valid
NDC Package Code : 64374-004
Start Marketing Date : 2016-07-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19822
Submission : 2006-10-02
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 11195
Submission : 1994-11-16
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36869
Submission : 2022-03-23
Status : Active
Type : II
Certificate Number : CEP 2022-328 - Rev 00
Issue Date : 2024-12-13
Type : Chemical
Substance Number : 1191
Status : Valid
Date of Issue : 2025-07-22
Valid Till : 2028-07-07
Written Confirmation Number : WC-0104
Address of the Firm :

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 11098
Submission : 1994-09-26
Status : Inactive
Type : II

51
PharmaCompass offers a list of Clozapine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Clozapine manufacturer or Clozapine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Clozapine manufacturer or Clozapine supplier.
PharmaCompass also assists you with knowing the Clozapine API Price utilized in the formulation of products. Clozapine API Price is not always fixed or binding as the Clozapine Price is obtained through a variety of data sources. The Clozapine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Refraxol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Refraxol, including repackagers and relabelers. The FDA regulates Refraxol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Refraxol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Refraxol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Refraxol supplier is an individual or a company that provides Refraxol active pharmaceutical ingredient (API) or Refraxol finished formulations upon request. The Refraxol suppliers may include Refraxol API manufacturers, exporters, distributors and traders.
click here to find a list of Refraxol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
We have 24 companies offering Refraxol
Get in contact with the supplier of your choice: